Found vs MedVi: Compare Personalized Plans, Prices, and Care
Found vs MedVi: both offer telehealth weight-loss programs focused on GLP-1s and compounded medications, but they differ in price structure, care model, and medication options. Early verdict: Found emphasizes a biology-first personalized program with insurance options and plans starting as low as $39, while MedVi offers a simple no-clinic process with a promotional first month at $179 for compounded semaglutide.
How Found and MedVi differ on care model and personalization
Found frames its program around a biology-first approach that conducts a medical evaluation and builds a personalized, medically supervised plan addressing hormones, blood sugar regulation, sleep, and behavior. MedVi focuses on a simple online intake with no clinic visits, offering a clinician review and 24/7 certified medical support. Both use clinician review and telehealth, but Found highlights a broader metabolic evaluation while MedVi emphasizes convenience and continuous support.
See MedVi semaglutide from $179
Pricing and payment approach compared
Found advertises affordable monthly plans and says you can get started for as low as $39, with most insurance now accepted and Found handling insurance paperwork. MedVi promotes a winter promotional first month at $179 including fast, free shipping but notes ongoing standalone months cost more and a three-month plan is available at $649. MedVi operates on a cash-pay model for compounded prescriptions and does not bill insurance.
Check Found membership and insurance options
Medication options and regulatory notes
Found lists tirzepatide as well as semaglutide and mentions both compounded and branded GLP-1s, and it states branded medications may be available via insurance with specific terms. MedVi offers clinically dosed compounded semaglutide only, and its platform notes compounded GLP-1s are not FDA-approved and are not evaluated by FDA for safety, effectiveness, or quality. Both providers include regulatory notes that compounded medications are not FDA-approved.
Support, access, and program scope
MedVi highlights 24/7 support from certified medical professionals and a fully online process with no clinic visits. Found emphasizes a personalized medically supervised program that targets hormones, metabolism, lifestyle, and behavioral factors and states it handles insurance paperwork for eligible patients. MedVi notes its process includes clinician review and that clinicians retain discretion to prescribe compounded GLP-1s.
Direct comparison table
| Criteria | Found | MedVi |
|---|---|---|
| Starting price | Get started for as low as $39 | $179 first month (promo); then higher ongoing |
| Care model | Biology-first personalized, medically supervised | Simple online intake, no clinic visits, 24/7 support |
| Medications offered | Semaglutide, tirzepatide, compounded and branded options | Clinically dosed compounded semaglutide only |
| Insurance | Most insurance now accepted; Found handles paperwork | No. MedVi is cash-pay for compounded meds |
| Regulatory note | Compounded GLP-1s are not FDA-approved | Compounded medications are not FDA-approved |
| Support features | Holistic program targeting metabolism, hormones, lifestyle | 24/7 certified medical support; clinician review |
What each provider emphasizes most
Found emphasizes personalization, insurance acceptance for many patients, and a broader biology-based program that can include multiple medications. MedVi emphasizes a low promotional first month, no clinic visits, clinically dosed compounded semaglutide, and round-the-clock certified support.
Risks, limitations, and eligibility notes
Both providers state that compounded GLP-1 medications are not FDA-approved and that prescriptions are subject to provider review and clinical eligibility. Found notes certain medications are FDA-approved for conditions other than weight and includes specific offer and insurance terms. MedVi warns that results vary and that clinician discretion and screening determine eligibility.
Explore MedVi details and start the intake
View Found plans and personalized options
Final take: Found vs MedVi
In short, Found vs MedVi boils down to personalization and insurance access versus a streamlined, clinic-free semaglutide pathway. Choose Found if you want a biology-first, medically supervised program that accepts many insurance plans and offers multiple medication options. Choose MedVi if you want a simple online process, 24/7 certified support, and a promotional first month at $179 for compounded semaglutide.